HELINX

pharmaceuticals, namely, compositions for use in the inactivation of pathogens and cells for medical or diagnostic use; compositions for use in the processing and storage of blood products; compositions, namely, psoralens and other compounds that prevent cell proliferation of nucleic acid replication for use with a catheter in surgical procedures; diagnostic preparations for medical or diagnostic use in the fields of immunodiagnostics and molecular diagnostics; compositions for medical or diagnostic use for preventing cell proliferation or nucleic acid replication; vaccines